UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056658
Receipt number R000064758
Scientific Title Short- and long-term impact of neuromuscular electrical stimulation on skeletal muscle quantity and quality decline in acute stroke patients: a randomized controlled trial.
Date of disclosure of the study information 2025/01/13
Last modified on 2025/01/08 05:37:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The impact of electrical stimulation therapy on skeletal muscle quantity and quality decline in acute stroke patients.

Acronym

The impact of electrical stimulation therapy on skeletal muscle quantity and quality decline in acute stroke patients.

Scientific Title

Short- and long-term impact of neuromuscular electrical stimulation on skeletal muscle quantity and quality decline in acute stroke patients: a randomized controlled trial.

Scientific Title:Acronym

Short- and long-term impact of neuromuscular electrical stimulation on skeletal muscle quantity and quality decline in acute stroke patients

Region

Japan


Condition

Condition

Hospitalized patients immediately after stroke onset.

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether early electrical stimulation therapy can prevent the short-term decline in skeletal muscle quantity and quality in stroke patients, and to examine its impact on long-term daily activities.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skeletal muscle cross-sectional area and intramuscular adipose tissue assessed by computed tomography.

Key secondary outcomes

Muscle thickness and muscle echo intensity by ultrasound device.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

In the electrical stimulation group, electrical stimulation therapy (at a level where muscle contractions are visibly noticeable) will be administered once daily for at least 5 days, in addition to standard rehabilitation.

Interventions/Control_2

In the sham stimulation group, sensory-level electrical stimulation will be administered as sham therapy in addition to standard rehabilitation.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients hospitalized within 48 hours after stroke onset.
2.Patients who were capable of independent living prior to hospitalization.
3.Patients with motor paralysis in one upper limb and one lower limb, who were able to walk independently at the time of admission.
4.Patients without severe cardiovascular or respiratory diseases.
Only those who meet all four of the above criteria will be included.

Key exclusion criteria

1.Patients under 18 years of age.
2.Patients for whom measurements are difficult to perform.
3.Patients diagnosed with brainstem or cerebellar infarction or hemorrhage without unilateral motor paralysis.
4.Patients with motor paralysis in all four limbs.
5.Patients who were unable to get out of bed within the first week of hospitalization.
Those who meet any of the above five criteria will be excluded from the study.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Wataru
Middle name
Last name Yamauchi

Organization

Gifu Prefectural Tajimi Hospital

Division name

Department of Rehabilitation

Zip code

507-8522

Address

5-161, Maehata-cho, Tajimi-shi, Gifu, Japan

TEL

0572-22-5311

Email

yamauchi-wataru@tajimi-hospital.jp


Public contact

Name of contact person

1st name Wataru
Middle name
Last name Yamauchi

Organization

Gifu Prefectural Tajimi Hospital

Division name

Department of Rehabilitation

Zip code

507-8522

Address

5-161, Maehata-cho, Tajimi-shi, Gifu, Japan

TEL

0572-22-5311

Homepage URL


Email

yamauchi-wataru@tajimi-hospital.jp


Sponsor or person

Institute

Gifu Prefectural Tajimi Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gifu Prefectural Tajimi Hospital Ethics Committee

Address

5-161, Maehata-cho, Tajimi-shi, Gifu, Japan

Tel

0572-22-5311

Email

yamauchi-wataru@tajimi-hospital.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 01 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 12 Month 26 Day

Date of IRB

2024 Year 12 Month 26 Day

Anticipated trial start date

2025 Year 01 Month 13 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 01 Month 08 Day

Last modified on

2025 Year 01 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064758